HER2 Antibodies Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
HER2 è utilizzato per controllare la proteina sulla superficie cellulare che aiuta la cellula a crescere. HER2 sta per recettore 2 del fattore di crescita epidermico umano. È un membro della famiglia dei recettori del fattore di crescita epidermico umano. I cambiamenti in HER2 provocano la crescita del tumore. Se ci sono più di due cellule del gene HER2, ciò porta alla produzione di una quantità eccessiva di proteina HER2 e si chiama sovraespressione di HER2. L'espressione di HER2 viene rilevata sulle membrane cellulari delle cellule epiteliali del tratto gastrointestinale, del tratto urinario, della pelle, del seno e della placenta, nonché sul cuore e sulle cellule muscolari dello scheletro. Nel tessuto fatale, l'espressione di HER2 è per lo più più elevata rispetto al normale tessuto adulto.
DINAMICHE DEL MERCATO
Trastuzumab, che è un tipo per il mercato degli anticorpi HER2, è noto per la fetta più consistente le cui quote di mercato rappresentano il 62,1% delle entrate totali. Considerando che la crescita dell’incidenza del cancro al seno e l’aumento del costo del suo trattamento possono guidare il mercato. Tuttavia, a causa del prezzo elevato dei prodotti, il mercato del cancro al seno HER2 sta frenando il mercato. Inoltre, il mercato ha portato pochi farmaci e alcuni farmaci verranno lanciati nel periodo di previsione. Inoltre, la domanda di anticorpi HER2 sta registrando l'ingresso di un gran numero di nuovi farmaci sul mercato.
AMBITO DI MERCATO
L'"Analisi del mercato degli anticorpi HER2 fino al 2028" è uno studio specializzato e approfondito del settore sanitario con particolare attenzione all'analisi delle tendenze del mercato globale. L’obiettivo del rapporto è fornire una panoramica del mercato Anticorpi HER2 con una segmentazione completa del mercato per tipo e area geografica. Si prevede che il mercato degli anticorpi HER2 assisterà a una crescita elevata durante il periodo di previsione. Il rapporto fornisce statistiche chiave sullo stato del mercato dei principali attori del mercato Anticorpi HER2 e offre tendenze e opportunità chiave nel mercato.
SEGMENTAZIONE DEL MERCATO
Il mercato degli anticorpi HER2 è segmentato in base al tipo e all'area geografica. In base al tipo, il mercato è segmentato in trastuzumab, Lapatinib, ado-trastuzumab emtansine, pertuzumab e everolimus.
HER2 Antibodies Market: Strategic Insights
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Abnova Corporation
- Actavis
- Biocon Limited,
- Bio-Techne (Novus Biologicals, LLC)
- Celltrion, Inc.
- Genentech Inc. (F. Hoffmann-La Roche Ltd.)
- Green Cross
- InvivoGen
- Novartis AG
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- Trastuzumab
- Lapatinib
- Ado-trastuzumab emtansine
- Pertuzumab
- Everolimus
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- America del Nord
- Europa
- Asia-Pacifico
- America centrale e meridionale
Il rapporto fornisce una panoramica dettagliata del settore, comprese informazioni sia qualitative che quantitative. Fornisce una panoramica e previsioni del mercato degli anticorpi HER2 in base a vari segmenti. Fornisce inoltre stime sulle dimensioni del mercato e sulle previsioni dall’anno 2020 al 2028 rispetto a cinque regioni principali, vale a dire; Nord America, Europa, Asia-Pacifico (APAC), Medio Oriente e Africa (MEA) e Sud & America Centrale. Il mercato degli anticorpi HER2 per ciascuna regione viene successivamente suddiviso in sottosegmenti in base ai rispettivi paesi e segmenti. Il rapporto copre l'analisi e le previsioni di 18 paesi a livello globale insieme alle tendenze attuali e alle opportunità prevalenti nella regione.
Il rapporto analizza i fattori che influenzano il mercato degli anticorpi HER2 sia dal lato della domanda che dell'offerta e valuta ulteriormente le dinamiche di mercato che influenzano il mercato durante il periodo di previsione, ovvero fattori trainanti, restrizioni, opportunità e tendenza futura. Il rapporto fornisce anche un'analisi PEST esaustiva per tutte e cinque le regioni, vale a dire; Nord America, Europa, APAC, MEA e Sud & America Centrale dopo aver valutato i fattori politici, economici, sociali e tecnologici che influenzano il mercato degli anticorpi HER2 in queste regioni.
ATTORI DEL MERCATO
Il rapporto copre gli sviluppi chiave nel mercato degli anticorpi HER2 come strategie di crescita organiche e inorganiche. Diverse aziende si stanno concentrando su strategie di crescita organica come lanci di prodotti, approvazioni di prodotti e altri come brevetti ed eventi. Le strategie di crescita inorganica osservate nel mercato sono state acquisizioni e partnership & collaborazioni. Queste attività hanno aperto la strada all’espansione del business e della base clienti degli operatori del mercato. Si prevede che gli operatori del mercato degli anticorpi HER2 avranno opportunità di crescita redditizie in futuro con la crescente domanda per il mercato degli anticorpi HER2 nel mercato globale. Di seguito è riportato l'elenco di alcune aziende impegnate nel mercato degli anticorpi HER2.
Il rapporto include anche i profili delle principali aziende del mercato degli anticorpi HER2 insieme alle loro analisi SWOT e strategie di mercato. Inoltre, il rapporto si concentra sui principali attori del settore con informazioni quali profili aziendali, componenti e servizi offerti, informazioni finanziarie degli ultimi 3 anni, sviluppi chiave negli ultimi cinque anni.
- • B. Braun Melsungen AG• Bovie Medical Corporation• Conmed• Ethicon Endo-Surgery • Karl Storz• KLS Martin• Maxer Endoscopy GmbH• Tecnologie mediche•< span style="font-size: 10pt; font-family: verdana, ginevra, sans-serif;"> Medtronic• Olympus Corporation
The Insight Il team dedicato di ricerca e analisi del partner è composto da professionisti esperti con competenze statistiche avanzate e offre varie opzioni di personalizzazione nello studio esistente.
HER2 Antibodies Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ XX million |
Market Size by | US$ XX Million |
Global CAGR | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Tipo
|
Regions and Countries Covered |
Nord America
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
1. Abnova Corporation
2. Actavis
3. Biocon Limited,
4. Bio-Techne (Novus Biologicals, LLC)
5. Celltrion, Inc.
6. Genentech Inc. (F. Hoffmann-La Roche Ltd.)
7. Green Cross
8. InvivoGen
9. Novartis AG
10. Pfizer, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.